Q&A: Page 2
-
Q&A
Q&A: Penumbra CEO Adam Elsesser says new devices will drive changes in clot treatment
Penumbra has launched two devices that use computers to control suction of blood clots. That’s helped the company convert some surgeons from traditional methods of clot removal, like open surgery or drugs.
By Elise Reuter • July 7, 2023 -
Q&A
Q&A: Dexcom’s Lawver shares strategy behind CGM for non-insulin users
The continuous glucose monitor in development for people with Type 2 diabetes who don’t take insulin could expand the CGM market to 25 million more people in the U.S., the company’s new chief commercial officer said.
By Elise Reuter • June 30, 2023 -
Q&A
BD tech chief Beth McCombs talks about Parata acquisition, automation
As pharmacies and labs face cost pressures and staffing shortages, automation offers a way to save scarce healthcare dollars, McCombs says.
By Elise Reuter • June 16, 2023 -
Q&A
Friday Q&A: Biosense Webster’s Brooks and Hong talk about cardiac ablation
The leaders of Johnson & Johnson’s Biosense Webster unit see growth opportunities with new cardiac ablation technologies, despite a crowded field that includes Abbott, Boston Scientific and Medtronic.
By Elise Reuter • June 9, 2023 -
Q&A
How they built it: Florian Hillen wants to look at your teeth with his AI
Hillen is building a business on the premise that using artificial intelligence to examine dental X-rays can nearly double diagnostic accuracy, and help detect other diseases.
By Peter Green • June 7, 2023 -
Q&A
Friday Q&A: Stanford Biodesign’s Makower on expediting Medicare coverage for breakthrough devices
The director and co-founder of the Stanford Byers Center for Biodesign has been urging CMS to get patients access to breakthrough devices.
By Susan Kelly • Updated May 26, 2023 -
Q&A
Friday Q&A: Boston Scientific’s De Rosa on the rise of an AFib ‘game changer’
The Switzerland-based vice president of rhythm management for Europe, the Middle East and Africa expects a “massive shift” to pulsed field ablation from other atrial fibrillation treatments.
By Susan Kelly • May 5, 2023 -
Q&A
Friday Q&A: J&J’s Shan Jegatheeswaran talks about the ‘behind the scenes’ work of AI in medtech
The global head of digital solutions for J&J’s medtech unit says the intersection between software and how it’s used is an important, and often overlooked, aspect of AI.
By Elise Reuter • April 28, 2023 -
Q&A
Friday Q&A: Abbott’s Vish Charan on muscling into the leadless pacemaker market
Abbott is taking on Medtronic in the market for wireless devices to treat abnormally slow heart rhythms.
By Susan Kelly • April 21, 2023 -
Q&A
Friday Q&A: Medtronic’s Ajizian talks connected care ahead of unit spinoff
From supporting AI-driven medical interventions to freeing up providers from administrative tasks, remote patient monitoring is raising the bar for care, says Medtronic’s CMO for patient monitoring.
By Susan Kelly • April 15, 2023 -
Q&A
Friday Q&A: Movano takes on the women’s wearables market with a smart ring
Movano Health aims to stand out from the wearables crowd with a women’s health focus and strategy that is centered on obtaining FDA clearances.
By Susan Kelly • March 24, 2023 -
Q&A
Friday Q&A: A startup founder tackles the riddle of why we cough
Joe Brew, the founder of three-year-old Hyfe, sees the potential for cough-tracking technology to be as ubiquitous as blood-pressure cuffs.
By Susan Kelly • March 17, 2023 -
Q&A
Friday Q&A: A regulatory attorney breaks down the EU MDR transition
Amsterdam-based regulatory expert Erik Vollebregt explains the agreement this week to extend the deadlines to comply with the EU’s Medical Device Regulation, and the issues that still need to be addressed.
By Susan Kelly • March 10, 2023 -
Q&A
Friday Q&A: GE HealthCare’s Yoder on using AI to drive precision care
The healthcare technology and diagnostics firm, now a standalone company, will integrate the acquisition of AI software developer Caption Health under Yoder’s lead.
By Susan Kelly • Feb. 23, 2023 -
Q&A
Friday Q&A: Medtronic’s Chan talks patient monitoring spinoff, rise of home care
As more patients are moved out of expensive hospital beds, Medtronic sees a growing market for remote care in homes and long-term care facilities.
By Elise Reuter • Feb. 2, 2023 -
Q&A
Friday Q&A: For GE HealthCare, the future is digital, CEO Arduini says
Digital capabilities will be “the next big inflection” driving growth for GE’s newly independent healthcare business.
By Peter Green • Jan. 6, 2023 -
Q&A
Freenome CEO Mike Nolan talks colorectal cancer test, clinical trials
The San Francisco-based company recently enrolled a clinical trial for its blood-based cancer test but faces competition in the market for minimally invasive cancer tests.
By Elise Reuter • Dec. 22, 2022 -
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022 -
Q&A
MedTech Innovators: Tissium co-founder Maria Pereira on taking tech from bench to bedside
The MIT-trained scientist explains how she went from PhD candidate to startup founder whose company is preparing to commercialize a range of products for use in reconstructing damaged tissue.
By Susan Kelly • Nov. 30, 2022 -
Q&A
Friday Q&A: Embecta CEO talks BD spinoff, future of diabetes devices
Dev Kurdikar spoke with MedTech Dive about developing an insulin pump for patients with Type 2 diabetes and what’s next for the firm.
By Elise Reuter • Nov. 18, 2022 -
Q&A
Friday Q&A: GE HealthCare’s Shetty on building accurate AI tools
The executive, who leads the company’s effort to create an integrated suite of AI tools for hospitals, warns against overloading clinicians with unconnected information.
By Elise Reuter • Nov. 11, 2022 -
Q&A
Friday Q&A: FemTech Focus’s Barreto discusses women’s health innovations, funding challenges
The executive director of the nonprofit group explains why women's health is finally getting attention and what the FemTech revolution is all about.
By Susan Kelly • Nov. 4, 2022
To find more content, use the "Topics" in the menu above.